Holen Sie sich die Stockscreener-App
5.31
10.62%
0.51
Handel nachbörslich:
5.45
0.14
+2.64%
Sintx Technologies Inc Aktie (SINT) Neueste Nachrichten
Tethon3D Buys Sintx Subsidiary to Vertically Integrate Ceramic 3D Printing Materials - 3DPrint.com
SINTX Technologies Divests TA&T To Focus On Medical Devices - Nasdaq
SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market - GlobeNewswire
SINTX Technologies Sells Subsidiary TA&T to Tethon Corporation, Enhancing Financial Flexibility and Focus on Medical Innovations - Nasdaq
Sintx Technologies Sells Technology Assesment And Transfer Subsidiary -February 20, 2025 at 06:15 am EST - Marketscreener.com
Strategic Pivot: How SINTX's Latest Move Transforms Its Medical Device Future - StockTitan
This Healthcare Stock Rose Sharply On USPTO Issuance - The Globe and Mail
This Penny Stock Is Surging on Patent News. Analysts Think It Gain 1,300% From Here. - TradingView
S&P 500 Edges Higher; Analog Devices Earnings Top Views - Benzinga
“Technology Stocks to Watch: CSDX, LYT, SINT, TRNR, RSLS, CYCU, TRUG Market Momentum Building” - The Globe and Mail
Stock market news: OSR Holdings +104.18%, SiNtx Technologies +53.19% among top gainers during midday trading - Business Upturn
Stock market news: OSR Holdings skyrocketed by 109.97% while Nikola plunged by 39.67% during midday trading - Business Upturn
Analyzing SINT’s current quarter earnings projections - US Post News
Dow Dips 150 Points; US Housing Starts Fall In January - Benzinga
Stock market today: OSR Holdings +190.68%, SiNtx Technologies +59.22% among top gainers in early trading - Business Upturn
SINTX Shares Are On The Rise Today: What's Going On? - Benzinga
Top Premarket Gainers -February 19, 2025 at 07:40 am EST - Marketscreener.com
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Sintx Technologies awarded patent on silicon nitride material by USPTO - TipRanks
SINTX Technologies, Inc. Strengthens Patent Portfolio with Issuance of U.S. Patent No. 12,239,761 for Advanced Silicon Nitride Applications in Biomedical Sector - Nasdaq
SINTX Receives Issuance of U.S. Patent for Silicon - GlobeNewswire
Breakthrough Medical Implant Patent: How SINTX is Revolutionizing Surgical Materials - StockTitan
Sintx Technologies (SINT) to Release Earnings on Tuesday - Defense World
Sintx Technologies (NASDAQ:SINT) Shares Up 4.3% – Still a Buy? - Defense World
Before You Invest, Make Sure You Check This SINTX Technologies Inc (NASDAQ: SINT) Analysis - Stocks Register
SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications - GlobeNewswire
SINTX Secures Game-Changing Patent for Revolutionary Medical Implant Technology - StockTitan
Sintx Technologies Updates Executive Compensation Agreements - TipRanks
Sintx Technologies Appoints CEO Eric Olson to Board - TipRanks
SINT (SINTX Technologies) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) Capex-to-Operating-Cash-Flow : 0.00 (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) 3-Year Revenue Growth Rate : -54.60% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) EPS without NRI : $-164.41 (TTM As of Sep. 2024) - GuruFocus.com
Stock market news: Alector down -34.47%, SiNtx Technologies -32.97% among the biggest losers during mid day trading - Business Upturn
SINT (SINTX Technologies) ROE % Adjusted to Book Value : -443.54% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) FCF Margin % : -703.27% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) Momentum Rank : 1 (As of Nov. 26, 2024) - GuruFocus.com
SINTX Technologies (LTS:0A8S) Cyclically Adjusted Book per Share : $15,528.10 (As of Sep. 2024) - GuruFocus.com
SINTX Technologies (LTS:0A8S) Cyclically Adjusted PS Ratio : 0.01 (As of Nov. 25, 2024) - GuruFocus.com
SINTX Technologies (LTS:0A8S) Cyclically Adjusted Revenue p - GuruFocus.com
SINTX Technologies (LTS:0A8S) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
SINTX Technologies (LTS:0A8S) 3-Year EBITDA Growth Rate : 64.20% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) Owner Earnings per Share (TTM) : -13.28 (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) Price-to-Free-Cash-Flow : N/A (As of Nov. 23, 2024) - GuruFocus.com
SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment - The Manila Times
SINTX Technologies and NED Medical Partner to Advance - GlobeNewswire
SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment - GlobeNewswire Inc.
Sintx Technologies (NASDAQ:SINT) vs. LENSAR (NASDAQ:LNSR) Head-To-Head Contrast - Defense World
Sintx Technologies (NASDAQ:SINT) Stock Price Up 55.9% – Here’s Why - Defense World
Sintx Technologies Initiates Stock Repurchase Program - Yahoo Finance
SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer - GlobeNewswire
SINTX Technologies Names Wall Street Veteran Gregg Honigblum as Chief Strategy Officer | SINT Stock News - StockTitan
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase Program Boosts Investor Confidence - BP Journal
Sintx Technologies, Inc. authorizes a Buyback Plan. - Marketscreener.com
Stock Market News: Jowell Global +49.23%, FuelCell Energy +30.68% and others among the top gainers during mid dy trading - Business Upturn
Stock market today: Fate Therapeutics gains 70.79% whereas SiNtx Technologies rose by 38.73% in early trading - Business Upturn
Why SINTX Technologies Stock Is Up 50% - Benzinga
Pre-Market Buzz: Sintx Technologies (SINT) Stock Climbs Amid Share Buyback News - Stocks Telegraph
SINTX Technologies Launches $500K Stock Buyback Program, Targeting 20% of Shares | SINT Stock News - StockTitan
SINTX Technologies Announces Stock Repurchase Program - GlobeNewswire
Sintx Technologies Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
1.16%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):